| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.44 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |